scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "cardiovascular disease"

1 - 10 of 553,137 results for
 "cardiovascular disease"
Results per page:

Autoimmune diseases and cardiovascular risk.

Publication Type: Academic Journal

Source(s): Trends in molecular medicine [Trends Mol Med] 2022 Dec; Vol. 28 (12), pp. 1025-1027. Date of Electronic Publication: 2022 Nov 07.

Abstract: There are more than 80 different autoimmune diseases which collectively affect 4-8% of the world's population. In a recent study published in Lancet, Conrad et al. found that 19 autoimmune diseases are associated with a composite of cardiovascular dise...

View details

Inflammatory Bowel Disease and Cardiovascular Diseases.

Publication Type: Academic Journal

Source(s): The American journal of medicine [Am J Med] 2022 Dec; Vol. 135 (12), pp. 1453-1460. Date of Electronic Publication: 2022 Sep 02.

Abstract: Background: Emerging data showed patients with chronic inflammatory disorders, including inflammatory bowel disease, are more likely to develop atherosclerotic cardiovascular diseases, heart failure, and atrial fibrillation. This article aims to review...

View details

Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach.

Publication Type: Academic Journal

Source(s): Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Nov 12; Vol. 21 (1), pp. 240. Date of Electronic Publication: 2022 Nov 12.

Abstract: Background: Nonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-associated fatty liver disease ...

View details

Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map.

Publication Type: Academic Journal

Source(s): Systematic reviews [Syst Rev] 2022 Nov 12; Vol. 11 (1), pp. 238. Date of Electronic Publication: 2022 Nov 12.

Abstract: Background: Patients with chronic kidney disease (CKD) require a personalised strategy for cardiovascular risk management (CVRM) to reduce their high risk of cardiovascular morbidity and mortality. Despite their high risk, patients with CKD appear to b...

View details

CAC Density and Cardiovascular Risk: Is Less Really More?

Publication Type: Editorial & Opinion

Source(s): JACC. Cardiovascular imaging [JACC Cardiovasc Imaging] 2022 Nov; Vol. 15 (11), pp. 1941-1943. Date of Electronic Publication: 2022 Oct 19.

Abstract: Competing Interests: Funding Support and Author Disclosures Dr Villines is past president and current nonvoting member of the Board of Directors of the Society of Cardiovascular Computed Tomography. Dr Javaid has no relationships relevant to the conten...

View details

Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data.

Publication Type: Academic Journal

Source(s): Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Nov 23; Vol. 21 (1), pp. 255. Date of Electronic Publication: 2022 Nov 23.

Abstract: Background: Individuals diagnosed with and treated for type 1 diabetes (T1D) have increased risk of micro- and macrovascular disease and excess mortality. Improving cardiovascular (CV) risk factors in individuals with T1D is known to reduce diabetes- r...

View details

Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States.

Publication Type: Academic Journal

Source(s): Current medical research and opinion [Curr Med Res Opin] 2022 Nov; Vol. 38 (11), pp. 1785-1795. Date of Electronic Publication: 2022 Jun 27.

Authors:

Abstract: Objective: To report on the use of antihyperglycemic agents (AHAs) by age (i.e.

View details

Editorial commentary: COVID-19 as a cardiovascular disease risk factor.

Publication Type: Editorial & Opinion

Source(s): Trends in cardiovascular medicine [Trends Cardiovasc Med] 2022 Nov; Vol. 32 (8), pp. 476-478. Date of Electronic Publication: 2022 Jul 16.

View details

Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.

Publication Type: Academic Journal

Source(s): Journal of the American Heart Association [J Am Heart Assoc] 2022 Oct 18; Vol. 11 (20), pp. e025858. Date of Electronic Publication: 2022 Oct 10.

Abstract: In 2019, the European Society of Cardiology/European Atherosclerosis Society stated that apolipoprotein B (apoB) was a more accurate marker of cardiovascular risk than low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholest...

View details

Impact of Cardiovascular Diseases on Mortality in Gastric Cancer Patients with Preexisting Chronic Disease.

Publication Type: Academic Journal

Source(s): Yonsei medical journal [Yonsei Med J] 2022 Nov; Vol. 63 (11), pp. 1043-1049.

Authors:

Abstract: Purpose: Chronic diseases and cardiovascular diseases (CVD) have been independently linked to poorer cancer outcomes. This study investigated whether gastric cancer patients with hypertension, diabetes, or dyslipidemia have higher mortality if diagnose...

View details
sponsored